Biopharmaceuticals
Huifeng Bio-Pharmaceutical (HFGB) Information to Be Available Through Standard & Poor's Market Access Program
Published in Law and Health Weekly, July 19th, 2008
Huifeng Bio-Pharmaceutical Technology, Inc. (BULLETIN BOARD: HFGB) , a leading developer and producer of plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production in China, announced that its company information will be made available via Standard & Poor's Market Access Program, an information distribution service that enables subscribing publicly traded companies to have their company information disseminated to users of Standard & Poor's Advisor Insight. The company information to be made available through this program includes share price, volume, dividends, shares outstanding, company financial position, and earnings. Standard & Poor's...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- a Journey for 9/11
Retired NFL Great George Martin's Historic ''a Journey for 9/11'' Charitable Walk Will End in San Diego on Saturday, June 21 - A.M. Best Co.
BestWeek: After the Fall, Fence Mending at AIG - Addiction Medicine
Study results from Karolinska Institut, Department of Clinical Neuroscience provide new insights into addiction medicine in adolescents - Adventrx Pharmaceuticals, Inc.
ADVENTRX Settles Dispute With Former Licensee - Aetna
StarLine Group Provides Organ Transplant Options Through New Agreement with Aetna's Cofinity - Aggression
New aggression study findings recently were reported by researchers at American University - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
